Chordia Therapeutics Inc. 190AShort Interest
Estimated short interest in Chordia Therapeutics Inc. (190A) is 1.55% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Nomura International plc.
Estimated short interest
1.55%
±0.00%
Estimated position (shares)
1,218,400
As of 2026-11-18
Holders (0.5% or more)
1 firms
398 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2024-06-21 |
|---|---|
| Latest disclosure | 2026-11-16 (Nomura International plc, 1.55%) |
| Reporting institutions | 9 firms (398 reports) |
| Peak estimated short interest | 6.97% (2024-11-29, 4 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Nomura International plc
- Morgan Stanley MUFG Securities Co., Ltd.
- Integrated Core Strategies (Asia) Pte. Ltd.
- Barclays Capital Securities Ltd
- JPM Securities Japan Co Ltd.
- Others
1.55%
Estimated short interest, 2026-11-18
Nomura International plc1.55%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-16 | Nomura International plc | Position 1,218,400 shares | Ratio 1.55% | ▲0.08% | Holding |
| 2025-08-13 | MERRILL LYNCH INTERNATIONAL | Position 327,400 shares | Ratio 0.47% | ▼0.04% | Below 0.5% |
| 2025-11-06 | JPM Securities Japan Co Ltd. | Position 336,600 shares | Ratio 0.47% | ▼0.08% | Below 0.5% |
| 2026-03-03 | UBS AG | Position 280,600 shares | Ratio 0.38% | ▼0.27% | Below 0.5% |
| 2025-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 261,500 shares | Ratio 0.37% | ▼0.13% | Below 0.5% |
| 2024-10-23 | XTX Markets Pte Ltd | Position 96,100 shares | Ratio 0.14% | ▼0.36% | Below 0.5% |
| 2026-06-16 | Barclays Capital Securities Ltd | Position 88,200 shares | Ratio 0.11% | ▼0.43% | Below 0.5% |
| 2025-02-18 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 0 shares | Ratio 0.00% | ▼2.53% | Closed |
| 2026-05-13 | GOLDMAN SACHS INTERNATIONAL | Position 5,200 shares | Ratio 0.00% | ▼0.86% | Closed |
Disclosure History 398 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-16 | Nomura International plc | Position 1,218,400 shares | Ratio 1.55% | ▲0.08% | — |
| 2026-11-13 | Nomura International plc | Position 1,162,600 shares | Ratio 1.47% | ▼0.18% | — |
| 2026-11-09 | Nomura International plc | Position 1,302,900 shares | Ratio 1.65% | ▼0.12% | — |
| 2026-10-30 | Nomura International plc | Position 1,373,100 shares | Ratio 1.77% | ▼0.03% | — |
| 2026-10-29 | Nomura International plc | Position 1,397,300 shares | Ratio 1.80% | ▲0.05% | — |
| 2026-10-28 | Nomura International plc | Position 1,356,500 shares | Ratio 1.75% | ▼0.09% | — |
| 2026-10-23 | Nomura International plc | Position 1,427,000 shares | Ratio 1.84% | ▲0.10% | — |
| 2026-10-21 | Nomura International plc | Position 1,135,777 shares | Ratio 1.46% | ▼0.09% | — |
| 2026-10-20 | Nomura International plc | Position 1,200,677 shares | Ratio 1.55% | ▲0.10% | — |
| 2026-10-16 | Nomura International plc | Position 1,126,677 shares | Ratio 1.45% | ▼0.09% | — |
| 2026-10-15 | Nomura International plc | Position 1,195,677 shares | Ratio 1.54% | ▼0.11% | — |
| 2026-10-14 | Nomura International plc | Position 1,279,877 shares | Ratio 1.65% | ▼0.10% | — |
| 2026-10-13 | Nomura International plc | Position 1,356,077 shares | Ratio 1.75% | ▼0.08% | — |
| 2026-10-08 | Nomura International plc | Position 1,421,600 shares | Ratio 1.83% | ▲0.05% | — |
| 2026-10-06 | Nomura International plc | Position 1,384,600 shares | Ratio 1.78% | ▼0.12% | — |
| 2026-10-05 | Nomura International plc | Position 1,476,800 shares | Ratio 1.90% | ▲0.20% | — |
| 2026-10-02 | Nomura International plc | Position 1,316,600 shares | Ratio 1.70% | ▲0.30% | — |
| 2026-10-01 | Nomura International plc | Position 1,085,300 shares | Ratio 1.40% | ▲0.72% | — |
| 2026-09-30 | Nomura International plc | Position 532,900 shares | Ratio 0.68% | ▲0.44% | — |
| 2026-08-28 | Nomura International plc | Position 306,500 shares | Ratio 0.39% | ▼0.20% | Below 0.5% |
| 2026-08-20 | Nomura International plc | Position 457,500 shares | Ratio 0.59% | ▼0.07% | — |
| 2026-08-10 | Nomura International plc | Position 511,600 shares | Ratio 0.66% | ▼0.09% | — |
| 2026-08-07 | Nomura International plc | Position 581,500 shares | Ratio 0.75% | ▲0.08% | — |
| 2026-07-31 | Nomura International plc | Position 524,500 shares | Ratio 0.67% | ▼0.20% | — |
| 2026-07-30 | Nomura International plc | Position 675,300 shares | Ratio 0.87% | ▼0.05% | — |
| 2026-07-29 | Nomura International plc | Position 711,100 shares | Ratio 0.92% | ▲0.54% | — |
| 2026-07-21 | Nomura International plc | Position 349,300 shares | Ratio 0.45% | ▼0.13% | Below 0.5% |
| 2026-07-16 | Nomura International plc | Position 452,900 shares | Ratio 0.58% | ▲0.37% | — |
| 2026-06-16 | Nomura International plc | Position 141,200 shares | Ratio 0.18% | ▼0.71% | Below 0.5% |
| 2026-06-16 | Barclays Capital Securities Ltd | Position 88,200 shares | Ratio 0.11% | ▼0.43% | Below 0.5% |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PRISM BioLab Co.,LTD206A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Heartseed Inc.219A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |